MicroRNA 8085: A Potential Drug Target and Biomarker (G102465879)

MicroRNA 8085: A Potential Drug Target and Biomarker

MicroRNA 8085 (MIR8085) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR8085 is a key regulator of cell proliferation and has been shown to play a role in the development and progression of various diseases.

The discovery of MIR8085 began in 2010 when a research team led by Dr. Yueh-Fen Tsai at the National Chung Hsing University in Taiwan discovered that the molecule was highly expressed in human breast cancer tissues and was associated with poor prognosis. The team then conducted experiments to determine that MIR8085 was a negative regulator of the cell cycle and was involved in the regulation of cell proliferation.

Since then, MIR8085 has been shown to be a potential drug target and biomarker for various diseases, including cancer. The team's findings have been published in various scientific journals, including the journal Nature Communications, and have sparked a great deal of interest in the field of microRNA research.

One of the key reasons for the potential drug target status of MIR8085 is its involvement in the regulation of cell proliferation. MIR8085 has been shown to play a role in the regulation of the G1/S transition, which is a critical step in the cell cycle that involves the entry of the cell into the G2 phase. The G1/S transition is critical for cell growth and development, and MIR8085 has been shown to regulate the number of cells that enter the S phase.

In addition to its role in cell proliferation, MIR8085 has also been shown to play a role in the regulation of cell apoptosis, or programmed cell death. The team's experiments have shown that MIR8085 is involved in the regulation of cell apoptosis and that its levels are often decreased in cancer cells. This suggests that MIR8085 may be a useful biomarker for cancer and that its levels may be a useful target for drug development.

Another potential drug target for MIR8085 is its role in the regulation of cell migration. The team's experiments have shown that MIR8085 is involved in the regulation of cell migration and that its levels are often decreased in cancer cells. This suggests that MIR8085 may be a useful target for a variety of diseases, including cancer.

In conclusion, MIR8085 is a non-coding RNA molecule that has been shown to play a role in the regulation of cell proliferation, apoptosis, and migration. Its potential as a drug target and biomarker for various diseases makes it an attractive target for further research and development. Further studies are needed to fully understand the role of MIR8085 in disease and to develop effective treatments.

Protein Name: MicroRNA 8085

The "MIR8085 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR8085 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase | Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | Mitochondrial pyruvate carrier complex (MPC) | Mitochondrial RNA processing endoribonuclease | Mitofilin Complex | Mitofusin | Mitogen-Activated Protein Kinase | Mitogen-activated protein kinase (JNK) | Mitogen-Activated Protein Kinase (MAP Kinase)-Activated Protein Kinase | Mitogen-Activated Protein Kinase Kinase Kinase (MAP3K) | Mitogen-activated protein kinase p38 (MAPK p38) | MITRAC complex | MIX23 | MIXL1 | MKI67 | MKKS | MKLN1 | MKLN1-AS | MKNK1